Get started
Author

Elena Arellano

Improved Clinical Outcome of COVID-19 in Hematologic Malignancy Patients Receiving a Fourth Dose of Anti-SARS-CoV-2 Vaccine: An EPICOVIDEHA Report
2022 · Jon Salmanton-García, Francesco Marchesi, et al. · HemaSphere · 35
Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry
2023 · Jon Salmanton-García, Francesco Marchesi, et al. · EClinicalMedicine · 34
Remdesivir or Nirmatrelvir/Ritonavir Therapy for Omicron SARS-CoV-2 Infection in Hematological Patients and Cell Therapy Recipients
2023 · José Luis Piñana, Inmaculada Heras, et al. · Viruses · 18
PDF
Respiratory Viruses in Patients With Hematological Malignancy in Boreal Autumn/Winter 2023–2024: EPICOVIDEHA ‐ EPIFLUEHA Report
2024 · Jon Salmanton‐García, Francesco Marchesi, et al. · American Journal of Hematology · 17
Survival in multiple myeloma and SARS‐COV‐2 infection through the COVID‐19 pandemic: Results from the EPICOVIDEHA registry
2023 · Pellegrino Musto, Jon Salmanton‐García, et al. · Hematological Oncology · 16
PDF
Omicron SARS-CoV-2 infection management and outcomes in patients with hematologic disease and recipients of cell therapy
2024 · José Luis Piñana, Lourdes Vazquez, et al. · Frontiers in Oncology · 12
The mortality of COVID-19 in CML patients from 2020 until 2022: results from the EPICOVIDEHA survey
2023 · Shaimaa El-Ashwah, Jon Salmanton-García, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 10
PDF
Outcomes of SARS-CoV-2 infection in Ph-neg chronic myeloproliferative neoplasms: results from the EPICOVIDEHA registry
2023 · Monia Marchetti, Jon Salmanton-García, et al. · Therapeutic Advances in Hematology · 9
Beyond the Usual Suspects: RSV Infection in Patients With Hematological Malignancies Compared to Influenza and SARS‐COV‐2—A Report From the EPICOVIDEHA/EPIRESEHA Registry
2025 · Jon Salmanton‐García, Francesco Marchesi, et al. · American Journal of Hematology · 2
PDF
Underrated, Unvaccinated, Untreated: A Multinational Registry Analysis of Human Metapneumovirus in Hematological Malignancy, Insights From EPICOVIDEHA/EPIRESEHA Registry
2026 · Jon Salmanton-García, Francesco Marchesi, et al. · Open Forum Infectious Diseases · 1
P1521: Improved Clinical Outcome of Covid-19 in Haematologic Malignancy Patients Receiving a Fourth Dose of Anti-sars-cov-2 Vaccine: an Epicovideha Report
2023 · Jon Salmanton-García, Francesco Marchesi, et al. · HemaSphere
S292: Nirmatrelvir/ritonavir in Covid-19 Patients With Haematological Malignancies: a Report Fromthe Epicovideha Registry
2023 · Jon Salmanton-García, Francesco Marchesi, et al. · HemaSphere
Works count: 12
Citation count: 154
H-index: 8
I10-index: 7
Year
Topic
Type